Phase 2 study of erlotinib combined with adjuvant chemoradiation and chemotherapy in patients with resectable pancreatic cancer

Joseph M. Herman, Katherine Y. Fan, Aaron T. Wild, Amy Hacker-Prietz, Laura D. Wood, Amanda L. Blackford, Susannah Ellsworth, Lei Zheng, Dung T. Le, Ana De Jesus-Acosta, Manuel Hidalgo, Ross C. Donehower, Richard D. Schulick, Barish H. Edil, Michael A. Choti, Ralph H. Hruban, Timothy M. Pawlik, John L. Cameron, Daniel A. Laheru, Christopher L. Wolfgang